Genomic abnormalities in ALKBH7 significantly reduced CD8+ T-cell immune infiltration, while CD8+ T-cell depletion significantly reduced immune surveillance capacity and the ability to clear tumor cells [39–41]. This evidence concerns the gene CD8A and neoplasm.